加拿大3 d生物打印公司方面生物系统has launched a new grant program whereby the selected applicants will be supplied with the company’s proprietary RX1 bioprinters. The developer of the…
Aspect Biosystems 3D bioprinting selected for $2.2M cancer drug development project
Canadian 3D bioprinting technology company Aspect Biosystems has announced its involvement in a $2.2 million project seeking to find new treatments for cancer. Starting this year, the company will be …
Aspect Biosystems 3D bioprinting kidney tissue with Maastricht University
3D bioprinting technology company Aspect Biosystems has announced a collaboration with Maastricht University (UM) in the Netherlands. The focus of their project is to develop viable kidney tissue for …
Aspect Biosystems receives $1M for “meaningful impact” of 3D bioprinting in healthcare
3D bioprinting technology company Aspect Biosystems was founded with the intention to have a “meaningful impact” on patient care. The company’s aim is to create human tissues on dema…